Application 090309
- Type
- ANDA
- Sponsor
- MYLAN PHARMA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE | ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE | TABLET; ORAL | EQ 300MG BASE; 150MG; 300MG | No | No |
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 9266 | ORIG | 2009-07-20 |